Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Warning Letter Pilot Discontinued; OCC Review Cited As Alternative

This article was originally published in The Gray Sheet

Executive Summary

The Medical Device Initiative Grassroots Task Force will be briefed regularly on FDA's warning and untitled letter activities, following the agency's decision to end its device center warning letter pilot program
Advertisement

Related Content

FDA To Release Warning Letter Responses, Sans Some Related Materials
FDA To Release Warning Letter Responses, Sans Some Related Materials
RAPS In Brief
RAPS In Brief
"Grassroots" Suggested Changes Useful But Resource-Intensive - Feigal
Device warning letter pilot
Device warning letter pilot
Advertisement
UsernamePublicRestriction

Register

MT017906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel